Novo's GLP-1 Proves Ineffective in Halting Alzheimer's Progression, Resulting in a 10% Drop in Share Value

Novo’s GLP-1 Proves Ineffective in Halting Alzheimer’s Progression, Resulting in a 10% Drop in Share Value